- Home
- RFL vs RENB Comparison
RFL vs RENB Comparison
Compare RFL & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFL
- RENB
- Stock Information
- Founded
- RFL 2017
- RENB 2011
- Country
- RFL United States
- RENB United States
- Employees
- RFL N/A
- RENB N/A
- Industry
- RFL Real Estate
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- RFL Finance
- RENB Health Care
- Exchange
- RFL Nasdaq
- RENB Nasdaq
- Market Cap
- RFL 74.4M
- RENB 69.7M
- IPO Year
- RFL N/A
- RENB N/A
- Fundamental
- Price
- RFL $1.92
- RENB $0.28
- Analyst Decision
- RFL
- RENB
- Analyst Count
- RFL 0
- RENB 0
- Target Price
- RFL N/A
- RENB N/A
- AVG Volume (30 Days)
- RFL 202.8K
- RENB 1.3M
- Earning Date
- RFL 06-11-2025
- RENB 05-15-2025
- Dividend Yield
- RFL N/A
- RENB N/A
- EPS Growth
- RFL N/A
- RENB N/A
- EPS
- RFL N/A
- RENB N/A
- Revenue
- RFL $732,000.00
- RENB N/A
- Revenue This Year
- RFL N/A
- RENB N/A
- Revenue Next Year
- RFL N/A
- RENB N/A
- P/E Ratio
- RFL N/A
- RENB N/A
- Revenue Growth
- RFL 35.56
- RENB N/A
- 52 Week Low
- RFL $1.28
- RENB $0.26
- 52 Week High
- RFL $3.19
- RENB $2.10
- Technical
- Relative Strength Index (RSI)
- RFL 47.49
- RENB 41.71
- Support Level
- RFL $1.82
- RENB $0.30
- Resistance Level
- RFL $2.16
- RENB $0.35
- Average True Range (ATR)
- RFL 0.13
- RENB 0.03
- MACD
- RFL -0.04
- RENB -0.00
- Stochastic Oscillator
- RFL 21.05
- RENB 10.43
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.